Advisory Board (NYSE:ABCO) price target upped to $50.00, released a report earlier today by Barclays Capital
- Updated: September 30, 2016
Reporting a potential upside of 0.12%, Barclays Capital upped the price target of Advisory Board (NYSE:ABCO) to $50.00
Yesterday Advisory Board (NYSE:ABCO) traded 2.63% higher at $44.70. Advisory Board’s 50-day moving average is $42.62 and its 200-day moving average is $36.32. The last stock price is up 23.63% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same time. 104,932 shares of the stock were exchanged, down from an avg. volume of 271,662
With a total market value of $0, Advisory Board has with a one year low of $18.87 and a one year high of $54.84 .
A total of 15 equity analysts have released a ratings update on ABCO. zero equity analysts rating the company a strong buy, zero brokerages rating the company a buy, zero brokerages rating the company a hold, zero brokerages rating the company a underperform, and finally zero brokerages rating the company a sell with a 12-month price target of $43.27.
General Company Details For Advisory Board (NYSE:ABCO)
The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company's healthcare programs address a range of clinical and business issues, including physician alignment and engagement, network management and growth strategy, value-based care and population health, revenue cycle, clinical operations and supply chain. Its higher education programs support colleges and universities in enrollment management; academic programming and student learning; faculty recruitment and retention; student advising and success; alumni affairs and advancement, and college and university operations. The Company offers distinct membership programs, across four areas, which include best practices research and insight, performance technology software, consulting and management services, and data- and tech-enabled services. Its best practices research and insight programs provide the foundation for all of its other programs.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.